Inventor
JENDZA KEITH
US23 patents
⚠️ This page may combine multiple inventors who share the name “JENDZA KEITH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLEGRETTI PAUL
7 patentsUS8158659B2Apr 17, 2012
Dual-acting imidazole antihypertensive agents
ALLEGRETTI PAUL11 citations92
US8895755B2Nov 25, 2014
Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
ALLEGRETTI PAUL3 citations73
US8569351B2Oct 29, 2013
Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity
ALLEGRETTI PAUL3 citations73
US8236846B2Aug 7, 2012
Dual-acting antihypertensive agents
ALLEGRETTI PAUL5 citations73
US9150514B2Oct 6, 2015
Dual-acting antihypertensive agents
ALLEGRETTI PAUL1 citations62
US9198899B2Dec 1, 2015
Dual-acting benzoimidazole antihypertensive agents
ALLEGRETTI PAUL0 citations51
US8637676B2Jan 28, 2014
Dual-acting benzoimidazole antihypertensive agents
ALLEGRETTI PAUL0 citations51
THERAVANCE INC
5 patentsUS7879896B2Feb 1, 2011
Dual-acting imidazole antihypertensive agents
THERAVANCE INC53 citations98
US8013005B2Sep 6, 2011
Dual-acting antihypertensive agents
THERAVANCE INC42 citations96
US7777077B2Aug 17, 2010
Dual-acting antihypertensive agents
THERAVANCE INC34 citations91
US8344013B2Jan 1, 2013
Dual-acting imidazole antihypertensive agents
THERAVANCE INC4 citations74
US8349875B2Jan 8, 2013
Dual-acting antihypertensive agents
THERAVANCE INC3 citations73
NOVARTIS AG
5 patentsUS11548865B2Jan 10, 2023
2-azaspiro[3.4]octane derivatives as M4 agonists
NOVARTIS AG2 citations70
US11485742B2Nov 1, 2022
2-azaspiro[3.4]octane derivatives as M4 agonists
NOVARTIS AG2 citations70
US12122761B2Oct 22, 2024
2-azaspiro[3.4]octane derivatives as M4 agonists
NOVARTIS AG0 citations59
US11820778B2Nov 21, 2023
2-azaspiro[3.4]octane derivatives as M4 agonists
NOVARTIS AG0 citations59
US12129246B1Oct 29, 2024
Hydroquinazoline derivatives for the treatment of a disease or disorder
NOVARTIS AG0 citations45